enkephalin, leucine has been researched along with Cerebral Infarction, Middle Cerebral Artery in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abbruscato, TJ; Karamyan, VT; Shah, K; Wang, H; Yang, L | 1 |
1 other study(ies) available for enkephalin, leucine and Cerebral Infarction, Middle Cerebral Artery
| Article | Year |
|---|---|
Characterization of neuroprotective effects of biphalin, an opioid receptor agonist, in a model of focal brain ischemia.
Topics: Animals; Brain; Brain Edema; Brain Ischemia; Cell Size; Cells, Cultured; Disease Models, Animal; Drug Evaluation, Preclinical; Enkephalins; Hippocampus; Infarction, Middle Cerebral Artery; Male; Mice; Molecular Targeted Therapy; Motor Activity; Nerve Degeneration; Neuroprotective Agents; Protein Kinase C; Receptors, Opioid; Sodium-Potassium-Chloride Symporters; Stroke | 2011 |